Update on BP Measurement, ABPM, home/self and clinic...how does office automated fit in?
|
|
- Mae Hicks
- 7 years ago
- Views:
Transcription
1 Update on BP Measurement, ABPM, home/self and clinic...how does office automated fit in? 8.00 to slides Maximum Blood Pressure is a Moving Target
2 Disclosures Martin Dawes Family Doctor (just) Head of Family Practice at UBC No Pharma work for 3 years Expert 24 company to help with risk prediction algorithms for Norwich Union and others every year
3 Blood Pressure is a Moving Target
4 Digit Preference (Random popn)
5 Hypertensive? Or Normotensive? 5
6 Ambulatory BP Gold Standard (unless intra arterial considered) $599 to $1700 Use one used in trials FDA approved with a BHS AAMI algorithm connects to a computer Don t use without a computer Use just the averages
7 Hazard ratios (95%ci) by systolic blood pressure adjusted for age and gender, and stratified by cohort. (I) Clinic BP Hazard ratio (95% CI) This steeper gradient of hazard ratios through the range indicates that ABP is a stronger predictor of mortality Ambulatory BP Hazard ratio (95% CI) ( 0.57, 1.25) ( 0.52, 1.06) ( 0.47, 0.94) ( 0.57, 1.10) ( 0.57, 1.10) ( 0.59, 1.19) ( 0.54, 1.14) 200+ mmhg 1.13 ( 0.80, 1.59) ( 0.68, 1.16) ( 0.70, 1.16) ( 0.75, 1.24) ( 0.91, 1.53) ( 1.08, 1.86) ( 1.27, 2.30) ( 1.33, 2.81) 200+ mmhg 1.95 ( 1.28, 2.97) Hazard ratio Hazard ratio 7
8 What is WCH? White coat hypertension is defined when a patient has a persistently elevated clinic BP and a normal home or ambulatory BP day time average i.e. <135/85mmHg. Hypertension (WCH) 15% to 30% of the population It is more common in pregnancy and with increasing age.
9 White Coat Hypertension is Safe Prognostic Value of White-Coat and Masked Hypertension Diagnosed by Ambulatory Monitoring in Initially Untreated Subjects: An Updated Meta Analysis Sante D. Pierdomenico and Franco Cuccurullo
10 Masked Hypertension where clinic BP is normal but ABPM and/or HBPM measurements are elevated Prevalence ~20%
11 The prognosis of masked hypertension Prevalence of masked hypertension is approximately 10% in the general population but is higher in patients with diabetes J Hypertension 2007;25:
12 Masked Hypertension Prognostic Value of White-Coat and Masked Hypertension Diagnosed by Ambulatory Monitoring in Initially Untreated Subjects: An Updated Meta Analysis Sante D. Pierdomenico and Franco Cuccurullo
13 National Institute of Clinical Excellence 2011 If the first and second blood pressure measurements taken during a consultation are both higher than 140/90 mmhg, offer 24-hour ambulatory blood pressure monitoring (ABPM) to confirm the diagnosis of hypertension.
14 Better testing cost less The savings with ambulatory monitoring compared with monitoring in the clinic and the home were primarily because of the costs of hypertensive treatment that were avoided because of the higher specificity of ambulatory monitoring. The discounted treatment costs for men aged 60 years were 776 for monitoring in the clinic compared with 744 for monitoring in the home and 631 for ambulatory monitoring.
15 Why?: Cost effectiveness Lovibond, K., Jowett, S., Barton, P., Caulfield, M., Heneghan, C., Hobbs, F. R., Hodgkinson, J., et al. (2011). Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. The Lancet. doi: /s (11)61184
16 Office Cannot detect WCH or Masked Hypertension But ABPM is expensive The equipment Needs computer analysis Two appointments Plan B Automated Office BP
17 Home BP Needs a valid tool Readings recorded in duplicate in the morning (from 6 to 10 a.m.) and night (from 8 p.m. to 12 p.m.) with an interval of 2 min between each, for 3 consecutive days (on weekdays if the patient works, or according to their normal activity if they are retired). To calculate the mean BP, the readings of the first day are excluded and the first and second readings of each morning night period of the second and third days were used.
18 Ambulatory blood pressure monitoring versus selfmeasurement of blood pressure at home: correlation with target organ damage. Gaborieau, Valerie; Delarche, Nicolas; Gosse, Philippe Journal of Hypertension. 26(10): , October DOI: /HJH.0b013e32830c Lippincott Williams & Wilkins, Inc. Published by Lippincott Williams & Wilkins, Inc. 2
19 Cut Point for WCH Home blood pressure self-monitoring: diagnostic performance in white-coat hypertension. Bayo, Joan; Cos, Francesc; Roca, Carme; Dalfo, Antoni; Martin-Baranera, Maria; Albert, Botey Blood Pressure Monitoring. 11(2):47-52, April DOI: /01.mbp Fig. 1 Receiver operating characteristic curve comparing different blood pressure cut-off points in the diagnosis of white-coat hypertension (BP <135/85 mmhg for ABPM )with home blood pressure self-monitoring (hbpsm). Black dots represent normality cut-off points for hbpsm in mmhg. 190 patients Two tests (hbpsm and ABPM) were compared in a series of patients aged from 18 to 80 years with mild moderate hypertension selected consecutively and without previous antihypertensive treatment. Recruited in primary care 2006 Lippincott Williams & Wilkins, Inc. Published by Lippincott Williams & Wilkins, Inc. 2
20 Automated Office Measures BP alone Does it 6 times BPTru Does it three times with Intellisense Takes averages
21 ROC Curves for AOBP and Home BP for detecting raised ABPM very similar diagnostic characteristics (if done well) Beckett (AOBP) ->Systolic Target Achieved on ABPM (<135 mmhg mean daytime blood pressure) Bayo -> (Home) The normality cut-off point for outpatient tests in the comparative study was a mean diurnal BP <135/ 85 mmhg for ABPM
22 Sensitivity ROC Curves for AOBP and Home BP for detecting raised ABPM Bayo 135 Beckett Log. (Bayo) 125 Log. (Beckett) Specificity
23 Diagnostic algorithm for high Blood Pressure including Office, ABPM and Home Blood Pressure Measurement BP: / Clinic BP ABPM (If available) HBPM Hypertension visit SBP or 100 DBP < 160 / 100 or Hypertension visit 4-5 Diagnosis of HTN ABPM or HBPM Awake BP < 135/85 and 24-hour < 130/80 Awake BP 135 SBP or 85 DBP Or 24-hour 130 SBP or 80 DBP or < 135/ SBP or DBP SBP or 90 DBP Diagnosis of HTN Continue to followup Diagnosis of HTN Continue to follow-up Diagnosis of HTN < 140 / 90 Continue to follow-up
24 My Own Proposed Algorithm for AOBP/Home BP in Clinical Practice in non diabetic or renal patients (not validated and not policy) AOBP/Home < 130/80 > 140/90 Continue to follow / h ABPM Diagnosis of Hypertension Awake BP < 135/85 and 24-hour < 130/80 Awake BP 135 SBP or 85 DBP Or 24-hour 130 SBP or 80 DBP
Measurement of Blood Pressure
Measurement of Blood Pressure Ambulatory and Home Blood Pressure Monitoring BHS Non Medical Prescribing Update MSc. Management of Hypertension in Primary Care University of Birmingham February 2013 Louise
More informationMEDICAL POLICY SUBJECT: AUTOMATED AMBULATORY BLOOD PRESSURE MONITORING
MEDICAL POLICY SUBJECT: AUTOMATED AMBULATORY 02/19/09 PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product covers
More informationa Centre de Médecine Cardiovasculaire, Paris, France and b Lebanese Received 7 June 2009 Revised 6 September 2009 Accepted 17 September 2009
Devices and technology 49 Validation of three automatic devices for self-measurement of blood pressure according to the International Protocol: The Omron M3 Intellisense (HEM-71-E), the Omron M2 Compact
More informationHypertension and Diabetes Status. 2011 Bangladesh Demographic and Health Survey
Hypertension and Diabetes Status 2011 Bangladesh Demographic and Health Survey Methodology and Sampling Total 18,000 households were selected nationwide (207 in urban and 393 in rural areas) One-third
More informationCorporate Medical Policy Ambulatory Blood Pressure Monitoring
Corporate Medical Policy Ambulatory Blood Pressure Monitoring File Name: Origination: Last CAP Review: Next CAP Review: Last Review: ambulatory_blood_pressure_monitoring 7/1982 4/2016 4/2017 4/2016 Description
More informationEXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA
EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA A CASE STUDY EXAMINING RISK FACTORS AND COSTS OF UNCONTROLLED HYPERTENSION ISPOR 2013 WORKSHOP
More informationThe Hypertension Treatment Center
Patricia F. Kao MD MS Asst Professor, EVMS Nephrology & HTN April 26, 2014 The Hypertension Treatment Center I have no conflicts of interest to disclose Objectives Describe the role of Hypertension Treatment
More informationJNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014
JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates January 30, 2014 GOALS Review key recommendations from recently published guidelines on blood pressure and cholesterol management Discuss
More informationSystolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
More informationMEDICAL POLICY No. 91503-R4 BLOOD PRESSURE MONITORS & AMBULATORY BLOOD PRESSURE MONITORING
BLOOD PRESSURE MONITORS & Effective Date: December 21, 2015 Review Dates: 01/05, 12/05, 12/06, 12/07, 12/08, 12/09, 12/10, 12/11, 12/12, 12/13, 11/14, 11/15 Date Of Origin: January 19, 2005 Status: Current
More informationAutomated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure
Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure Policy Number: 1.01.02 Last Review: 9/2015 Origination: 1/1989 Next Review:
More informationChronic Daily Headache and Blood Pressure Interrelated Prognosis
Blood pressure behaviour in chronic daily headache IJM Benseñor, PA Lotufo, D Mion-Jr & MA Martins Department of Medicine, School of Medicine of the University of São Paulo, São Paulo, Brazil Benseñor
More informationPrognostic impact of uric acid in patients with stable coronary artery disease
Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,
More informationCardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,
More informationEpidemiology of Hypertension 陈 奕 希 3120000591 李 禾 园 3120000050 王 卓 3120000613
Epidemiology of Hypertension 陈 奕 希 3120000591 李 禾 园 3120000050 王 卓 3120000613 1 Definition Hypertension is a chronic medical condition in which the blood pressure in the arteries is elevated. 2 Primary
More informationThe Cross-Sectional Study:
The Cross-Sectional Study: Investigating Prevalence and Association Ronald A. Thisted Departments of Health Studies and Statistics The University of Chicago CRTP Track I Seminar, Autumn, 2006 Lecture Objectives
More informationBarry P McGrath, and on behalf of the National Blood Pressure Advisory Committee of the National Heart Foundation of Australia
Information from the For more information contact Heartline 1300 362 787 or www.heartfoundation.com.au Ambulatory blood pressure monitoring Position Statement Barry P McGrath, and on behalf of the National
More information2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:
More informationAmbulatory blood pressure monitoring
STATEMENT POSITION STATEMENT Ambulatory blood pressure monitoring Barry P McGrath, and on behalf of the National Blood Pressure Advisory Committee of the National Heart Foundation of Australia THE DEVELOPMENT
More informationADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.
More informationAHA/ASH/PCNA Scientific Statement
AHA/ASH/PCNA Scientific Statement Call to Action on Use and Reimbursement for Home Blood Pressure Monitoring: Executive Summary A Joint Scientific Statement From the American Heart Association, American
More informationTelemedicine in Prevention and Chronic Disease Management
Telemedicine in Prevention and Chronic Disease Management William P. Santamore, PhD, Alfred A. Bove, MD, PhD Carol Homko, PhD, Temple University Telemedicine Research Center Philadelphia, PA AHRQ June
More informationADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,
More informationCancer Screening. Robert L. Robinson, MD, MS. Ambulatory Conference SIU School of Medicine Department of Internal Medicine.
Cancer Screening Robert L. Robinson, MD, MS Ambulatory Conference SIU School of Medicine Department of Internal Medicine March 13, 2003 Why screen for cancer? Early diagnosis often has a favorable prognosis
More informationDISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
More informationVasc Health Risk Manag. 2011; 7: 709 717. Published online 2011 November 30. doi: 10.2147/VHRM.S27193 PMCID: PMC3237100
Vasc Health Risk Manag. 2011; 7: 709 717. Published online 2011 November 30. doi: 10.2147/VHRM.S27193 PMCID: PMC3237100 Validation of four automatic devices for self-measurement of blood pressure according
More informationHai Fang, PhD Professor China Center for Health Development Studies Peking University
Hai Fang, PhD Professor China Center for Health Development Studies Peking University Presentation for Asia Health Policy Program at Stanford University November 7th, 2014 Outline Introduction Background
More informationBlood Pressure Assessment Program Screening Guidelines
Blood Pressure Assessment Program Screening Guidelines Assessment Pre-Assessment Prior to/during assessment, explain to client the following: What is meant by high blood pressure; What are the effects
More informationResults of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm
CHAPTER 6 Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm JW Haveman, A Karliczek, ELG Verhoeven, IFJ Tielliu, R de Vos, JH Zwaveling, JJAM
More informationHow to measure blood pressure using digital monitors
How to measure blood pressure using digital monitors What is high blood pressure? Blood pressure is the pressure exerted by circulating blood upon the walls of blood vessels. Systolic pressure is the blood
More informationDisclosure of Relationships
American Society of Hypertension, Inc. (ASH) Disclosure of Relationships Over the past 12 months Consultant: Novartis, Pfizer Advisory Board: Abbott Vascular, Gilead Partnership with the Patient to Improve
More informationCurrent Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology*
Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology* =Abstracts= Registry committee of Korean Society of Nephrology
More informationMarcus Wilson, PharmD. First Plenary Session
Moderator First Plenary Session THE USE OF "BIG DATA" - WHERE ARE WE AND WHAT DOES THE FUTURE HOLD? Marcus Wilson, PharmD HealthCore Wilmington, DE, USA Speakers First Plenary Session THE USE OF "BIG DATA"
More informationIf several different trials are mentioned in one publication, the data of each should be extracted in a separate data extraction form.
General Remarks This template of a data extraction form is intended to help you to start developing your own data extraction form, it certainly has to be adapted to your specific question. Delete unnecessary
More informationHow To Know If You Have Microalbuminuria
3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate
More information2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Measure #128 (NQF 0421): Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:
More informationPRACTICE PROBLEMS FOR BIOSTATISTICS
PRACTICE PROBLEMS FOR BIOSTATISTICS BIOSTATISTICS DESCRIBING DATA, THE NORMAL DISTRIBUTION 1. The duration of time from first exposure to HIV infection to AIDS diagnosis is called the incubation period.
More informationMortality Assessment Technology: A New Tool for Life Insurance Underwriting
Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Guizhou Hu, MD, PhD BioSignia, Inc, Durham, North Carolina Abstract The ability to more accurately predict chronic disease morbidity
More informationPHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.
PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1
More informationUnderstanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
More informationMeasure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care
Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of patients
More informationNHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)
NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia Produced by: National Cardiovascular Intelligence Network (NCVIN) Date: August 2015 About Public Health England Public Health England
More informationKomorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal
More informationAn accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A
BJOG: an International Journal of Obstetrics and Gynaecology DOI: 10.1111/j.1471-0528.2005.00617.x An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A
More informationThe Economic Impact and Cost-Effectiveness of Glucose Monitoring
The Economic Impact and Cost-Effectiveness of Glucose Monitoring William H. Herman, MD, MPH Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes Professor of Internal Medicine and Epidemiology University
More informationAggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost
Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Naftali Stern Institute of Endocrinology, Metabolism and Hypertension Tel Aviv -Sourasky Medical Center and Sackler
More informationDelivering Real World Evidence. Canada Let s Get Real!
Delivering Real World Evidence from Electronic Medical Records in Canada Let s Get Real! Neil Corner Director, Real World Evidence, IMS Brogan Alison Dziarmaga Director, Real World Evidence, AstraZeneca
More informationTelemonitoring Blood Pressure by Secure Message on a Patient Portal: Use, Content, and, Outcomes
Telemonitoring Blood Pressure by Secure Message on a Patient Portal: Use, Content, and, Outcomes Frederick North, William Ward, Muhamad Elrashidi, Paul Takahashi, Karen Ytterberg, Sidna Tulledge-Scheitel
More informationHypertension Diagnosis and Treatment
Health Care Guideline Hypertension Diagnosis and Treatment The November 2014, Fifteenth Edition of ICSI s Hypertension Diagnosis and Treatment Health Care Guideline incorporates a revision of our previous
More informationAppendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
More informationElevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality
Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality C. Tomas, MA Castel, E Roig, I. Vallejos, C. Plata, F. Pérez-Villa Cardiology Department,
More informationHEALTH EVIDENCE REVIEW COMMISSION (HERC) COVERAGE GUIDANCE: DIAGNOSIS OF SLEEP APNEA IN ADULTS DATE: 5/9/2013 HERC COVERAGE GUIDANCE
HEALTH EVIDENCE REVIEW COMMISSION (HERC) COVERAGE GUIDANCE: DIAGNOSIS OF SLEEP APNEA IN ADULTS DATE: 5/9/2013 HERC COVERAGE GUIDANCE The following diagnostic tests for Obstructive Sleep Apnea (OSA) should
More informationImputation of missing data under missing not at random assumption & sensitivity analysis
Imputation of missing data under missing not at random assumption & sensitivity analysis S. Jolani Department of Methodology and Statistics, Utrecht University, the Netherlands Advanced Multiple Imputation,
More informationJournal of Hypertension 2005, 23:505 511. a Department of Computer Science, b Applied Computing Institute of the Faculty
Original article 505 A reliable index for the prognostic significance of blood pressure variability Luis Mena a, Salvador Pintos b, Nestor V. Queipo b, José A. Aizpúrua c, Gladys Maestre c and Tulio Sulbarán
More informationThe Prevalence of Undiagnosed Hypertension in Ambulatory Emergency Department Patients and Lack of Adequate Referral
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 11-15-2006 The Prevalence of Undiagnosed Hypertension in Ambulatory
More informationDevice Equivalence Evaluation Form
Comparison of the Omron M3 (HEM-7131-E) with the Omron M6 AC (HEM-7322-E) Devices Omron M3 (HEM-7131-E) Omron M6 AC (HEM-7322-E) Pictures Display Validation ESH 2010 Device 1 Criteria Same Criteria Measurement
More informationQuality Improvement in Primary Care Settings
Quality Improvement in Primary Care Settings Eboni Price Haywood, MD, MPH Chief Medical Officer, Tulane Community Health Medical Director, Tulane Community Health @ Covenant House Team Approach to Quality
More informationThe minimum numbers required for each blood pressure group.
Validation of Stabil-O-Graph device for self-measurement of blood pressure according to the British Hypertension Society (BHS) standards and protocols. Dr. G.H.M ten Oever (a), Dr. Cortez-Campeáo (b),
More informationThe Prevalence and Determinants of Undiagnosed and Diagnosed Type 2 Diabetes in Middle-Aged Irish Adults
The Prevalence and Determinants of Undiagnosed and Diagnosed Type 2 Diabetes in Middle-Aged Irish Adults Seán R. Millar, Jennifer M. O Connor, Claire M. Buckley, Patricia M. Kearney, Ivan J. Perry Email:
More informationRenovascular Hypertension
Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension
More informationValue of Modified Early Warning Score Among Critically Ill Patients
Med. J. Cairo Univ., Vol. 78, No. 1, December: 1-7, 2010 www.medicaljournalofcairouniversity.com Value of Modified Early Warning Score Among Critically Ill Patients ASHRAF HUSSEIN ABD AL MOHSEN, M.D. and
More informationCohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More information2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk Lynne T Braun, PhD, CNP, FAHA, FAAN Professor of Nursing, Nurse Practitioner Rush University Medical Center 2
More informationHIGH BLOOD PRESSURE AND YOUR KIDNEYS
HIGH BLOOD PRESSURE AND YOUR KIDNEYS www.kidney.org About the Information in this Booklet Did you know that the National Kidney (NKF) Foundation offers guidelines and commentaries that help your healthcare
More informationMIND-BODY THERAPIES FOR HYPERTENSION
MIND-BODY THERAPIES FOR HYPERTENSION Systematic Review and Meta-Analysis Ather Ali, ND, MPH (1), David L. Katz, MD, MPH (1,2), Michael B. Bracken, PhD, MPH (2). (1)Yale-Griffin Prevention Research Center
More informationUsing multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration
Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Hiddo Lambers Heerspink Department of Clinical Pharmacology University Medical
More informationCritical Appraisal of Article on Therapy
Critical Appraisal of Article on Therapy What question did the study ask? Guide Are the results Valid 1. Was the assignment of patients to treatments randomized? And was the randomization list concealed?
More informationGuidelines for the management of hypertension in patients with diabetes mellitus
Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes
More informationLet s Do It Well. Nurse Learning Pack
Let s Do It Well Nurse Learning Pack Let s Do It Well Nurse Learning Pack Reviewed and agreed by the British Hypertension Society (BHS) and the Nurses Hypertension Association (NHA) HIT is an independent
More informationBayes Theorem & Diagnostic Tests Screening Tests
Bayes heorem & Screening ests Bayes heorem & Diagnostic ests Screening ests Some Questions If you test positive for HIV, what is the probability that you have HIV? If you have a positive mammogram, what
More informationIndividual patient data meta-analysis of continuous diagnostic markers
Individual patient data meta-analysis of continuous diagnostic markers J.B. Reitsma Julius Center for Health Sciences and Primary Care UMC Utrecht / www.juliuscenter.nl Outline IPD benefits Meta-analytical
More informationDefinition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013
Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:
More informationPlank 1 Tool: Hypertension Medical Assistant Training (Providence Medical Group)
Plank 1 Tool: Hypertension Medical Assistant Training (Providence Medical Group) Task Qualification Training Packet Volume 1 Date Performing Blood Pressure Checks SUBJECT AREA Vital Signs EQUIPMENT REQUIRED
More informationWork-site hypertension prevalence and control in three Central European Countries
(2004) 18, 581 585 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Work-site hypertension prevalence and control in three Central European Countries
More informationThe Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome
Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali
More informationNIHI Big Data in Healthcare Research Case Study
NIHI Big Data in Healthcare Research Case Study Professor Rob Doughty Heart Foundation Chair of Heart Health National Institute for Health Innovation and the Dept of Medicine, University of Auckland &
More informationThe OPALSO Prehospital Research Group OPALS
The O Prehospital Research Group The Resuscitation Outcomes Consortium Studies: Trauma Study Hypertonic Resuscitation following Traumatic Injury Purpose of the Study To determine if Hypertonic Saline with
More informationDemonstration Study of Healthcare Utilization by Obese Patients. Joseph Vasey PhD Director, Epidemiology Quintiles Outcome May 22, 2013
Demonstration Study of Healthcare Utilization by Patients Joseph Vasey PhD Director, Epidemiology Quintiles Outcome May 22, 2013 Copyright 2013 Quintiles Revised April 2013 Introduction Obesity in the
More informationCarefully review the risks and potential, but unproven, benefits of treatment.
Hypertension This is a consensus guideline for the pharmacological management of hypertension with frailty. This information was developed by the Dalhousie University Academic Detailing Service and the
More informationDRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Elhami et al. SJIF Impact Factor 5.210 Volume 4, Issue 11, 1159-1166 Research Article ISSN 2278 4357 DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE
More information24-hour blood pressure monitoring: its efficacy and techniques
Volume 4 Issue 12 Year 2011 HOT TOPICS IN HYPERTENSION Editor-in-chief Massimo Volpe 24-hour blood pressure monitoring: its efficacy and techniques Published three times a year ISSN 1973-963X www.hottopicsin.com
More informationHow To Improve Care At Geisinger
HIT AND HSR FOR ACTIONABLE KNOWLEDGE: DESCRIPTION OF PARTNERING HEALTH SYSTEMS PARTNER: Geisinger Health System History, Structure, and Size Geisinger Health System (GHS) is an integrated delivery system
More informationClinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
More informationPEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
More informationLeicester Nuffield Research Unit Trends in disease and how they will impact on disability in the older population
Leicester Nuffield Research Unit Trends in disease and how they will impact on disability in the older population R. Matthews, C. Jagger & MRC CFAS Background Projections of future numbers with disability
More informationMedical Statistics, School of Medicine, University of Athens, Greece
Original Research Hellenic J Cardiol 2012; 53: 432-438 Circadian Variation of Blood Pressure and Heart Rate in Normotensives, White-Coat, Masked, Treated and Untreated Hypertensives Eleni Koroboki 1, Efstathios
More informationHôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires
Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires Prof. J. Philippe Effect of estrogens on glucose metabolism : Fasting Glucose, HbA1c and C-Peptide
More information2013 ACO Quality Measures
ACO 1-7 Patient Satisfaction Survey Consumer Assessment of HealthCare Providers Survey (CAHPS) 1. Getting Timely Care, Appointments, Information 2. How well Your Providers Communicate 3. Patient Rating
More informationHigh Blood Pressure (Essential Hypertension)
Sacramento Heart & Vascular Medical Associates February 18, 2012 500 University Ave. Sacramento, CA 95825 Page 1 916-830-2000 Fax: 916-830-2001 What is essential hypertension? Blood pressure is the force
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Wu Y-T, Fratiglioni L, Matthews FE, et
More informationInaccuracy of wrist-cuff oscillometric blood pressure devices: an arm position artefact? Adnan Mourad a, Alastair Gillies a and Shane Carney a,b
Clinical methods and pathophysiology 67 Inaccuracy of oscillometric blood pressure devices: an arm position artefact? Adnan Mourad a, Alastair Gillies a and Shane Carney a,b Background Despite the increasing
More informationBarostimulaatio ja renaalinen denervaatio
Barostimulaatio ja renaalinen denervaatio Daniel Gordin, Dos, ol HYKS Vatsakeskus, Nefrologia FinnDiane Tutkimus, Folkhälsanin tutkimuskeskus, Helsingin yliopisto Valtakunnallinen hypertensiopäivä Messukeskus,
More informationFrom Concept to Rapid Visualization a Data Analytics Case Study
From Concept to Rapid Visualization a Data Analytics Case Study Gregory Wozniak, PhD Director of Outcomes Analytics Health Outcomes Group American Medical Association The Journey Objectives Share experiences
More informationPsoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
More informationHindrik Vondeling Department of Health Economics University of Southern Denmark Odense, Denmark
Health technology assessment: an introduction with emphasis on assessment of diagnostic tests Hindrik Vondeling Department of Health Economics University of Southern Denmark Odense, Denmark Outline λ Health
More informationAir Pollution and Public Health
Air Pollution and Public Health Where have we been? Where are we going? Joel Schwartz Harvard School of Public Health Meuse Valley Disaster December 1 5 1930 Intense Fog in valley between Liege and
More informationDIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE
DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE 40 yo woman, BMI 36. Motivated to begin diet therapy. Which of the following is contraindicated: Robert B. Baron MD MS Professor and
More informationPSA Screening and the USPSTF Understanding the Controversy
PSA Screening and the USPSTF Understanding the Controversy Peter C. Albertsen Division of Urology University of Connecticut Farmington, CT, USA USPSTF Final Report 1 Four Key Questions 1. Does PSA based
More informationEvidence-Based Secondary Stroke Prevention and Adherence to Guidelines
Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines Mitchell S.V. Elkind, MD, MS Associate Professor of Neurology Columbia University New York, NY Presenter Disclosure Information Mitchell
More informationHow To Determine Pad
Process Representation #1 : The PAD algorithm as a sequential flow thru all sections An exploded version of the above scoped section flow is shown below. Notes: The flow presupposes existing services (
More information